NASDAQ : ACRS
Aclaris Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 3.97 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 615.29M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Aclaris Therapeutics, Inc. (ACRS) reported revenue of 8.22M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 8.22M | 7.83M | 18.72M | 31.25M | 29.50M | 6.64M |
| Other Revenue | 257.00K | 122.00K | ||||
| Revenue | 8.22M | 7.83M | 18.72M | 31.25M | 29.75M | 6.76M |
| Cost of Revenue | 70.49M | 59.93M | 49.04M | 114.25M | 89.77M | 48.53M |
| Gross Profit | -62.27M | -52.10M | -30.32M | -83.00M | -60.02M | -41.77M |
| Selling, General & Admin | 23.24M | 21.97M | 22.20M | 31.51M | 25.13M | 23.62M |
| Operating Expenses | 23.24M | 21.97M | 22.20M | 31.51M | 25.13M | 23.62M |
| Operating Income | -85.51M | -74.08M | -52.53M | -114.51M | -85.15M | -65.38M |
| Interest & Investment Income | 6.73M | 7.64M | 7.95M | 8.51M | ||
| Other Non Operating Income (Expenses) | 3.85M | 3.81M | 1.91M | 2.95M | -1.14M | |
| EBT Excluding Unusual Items | -74.94M | -62.62M | -42.66M | -106.00M | -82.21M | -66.53M |
| Merger & Restructuring Charges | -3.12M | |||||
| Other Unusual Items | -800.00K | -2.30M | -2.50M | 26.90M | -4.70M | -24.34M |
| Pretax Income | -75.74M | -64.92M | -132.06M | -88.85M | -86.91M | -90.86M |
| Income Tax Expense | -367.00K | |||||
| Earnings From Continuing Operations | -75.74M | -64.92M | -132.06M | -88.48M | -86.91M | -90.86M |
| Net Income | -75.74M | -64.92M | -132.06M | -88.48M | -86.91M | -90.86M |
| Net Income to Common | -75.74M | -64.92M | -132.06M | -88.48M | -86.91M | -90.86M |
| Shares Outstanding (Basic) | 129.23M | 122.56M | 77.30M | 69.81M | 65.21M | 56.73M |
| Shares Outstanding (Diluted) | 129.23M | 122.56M | 77.30M | 69.81M | 65.21M | 56.73M |
| EPS (Basic) | -0.59 | -0.53 | -1.71 | -1.27 | -1.33 | -1.60 |
| EPS (Diluted) | -0.59 | -0.53 | -1.71 | -1.27 | -1.33 | -1.60 |
| Free Cash Flow | -62.18M | -47.22M | -20.20M | -79.63M | -68.17M | -52.44M |
| Free Cash Flow Per Share | -0.48 | -0.39 | -0.26 | -1.14 | -1.04 | -0.92 |
| Gross Margin | -161.99% | -265.60% | -201.74% | |||
| Operating Margin | -1,040.43% | -946.52% | -280.59% | -366.44% | -286.21% | -967.08% |
| Profit Margin | -921.50% | -829.58% | -705.48% | -283.15% | -292.11% | -1,343.96% |
| Free Cash Flow Margin | -756.50% | -603.42% | -107.89% | -254.84% | -229.13% | -775.65% |
| EBITDA | -85.53M | -74.03M | -52.22M | -114.45M | -65.06M | |
| EBITDA Margin | -278.95% | |||||
| D&A For EBITDA | -12.00K | 40.00K | 307.00K | 63.00K | 324.00K | |
| EBIT | -85.51M | -74.08M | -52.53M | -114.51M | -85.15M | -65.38M |
| EBIT Margin | -280.59% | -286.21% | ||||
| Revenue as Reported | 8.22M | 7.83M | 18.72M | 31.25M | 29.75M | 6.76M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 19.17M | 19.96M | 24.57M | 39.88M | 45.28M | 27.35M |
| Short-Term Investments | 72.39M | 70.79M | 89.02M | 79.23M | 172.29M | 164.06M |
| Cash & Short-Term Investments | 91.56M | 90.75M | 113.59M | 119.11M | 217.57M | 191.41M |
| Receivables | 6.21M | 5.57M | 12.36M | 298.00K | 484.00K | 623.00K |
| Prepaid Expenses | 9.45M | 13.49M | 12.99M | |||
| Total Current Assets | 97.77M | 96.32M | 125.95M | 128.86M | 231.55M | 205.03M |
| Property, Plant & Equipment | 2.65M | 3.05M | 3.85M | 5.48M | 3.78M | 4.77M |
| Long-Term Investments | 79.06M | 60.61M | 90.30M | 62.77M | 12.24M | 34.24M |
| Other Intangible Assets | 6.97M | 7.05M | ||||
| Other Long-Term Assets | 212.00K | 486.00K | 224.00K | 299.00K | 52.00K | 117.00K |
| Total Assets | 179.69M | 160.46M | 220.33M | 197.41M | 254.60M | 251.21M |
| Accounts Payable | 15.52M | 13.16M | 4.69M | 8.88M | 10.35M | 9.98M |
| Accrued Expenses | 4.59M | 7.41M | 7.76M | 10.86M | 8.20M | 7.37M |
| Current Portion of Leases | 588.00K | 551.00K | 481.00K | 426.00K | 684.00K | 722.00K |
| Current Unearned Revenue | 3.98M | 3.94M | 3.89M | |||
| Other Current Liabilities | 3.57M | 3.58M | 14.77M | 10.79M | 2.70M | 4.85M |
| Total Current Liabilities | 28.24M | 28.64M | 31.60M | 30.95M | 21.94M | 22.93M |
| Long-Term Leases | 1.26M | 1.56M | 2.12M | 3.07M | 1.57M | 2.17M |
| Long-Term Unearned Revenue | 14.31M | 16.17M | 20.04M | |||
| Long-Term Deferred Tax Liabilities | 367.00K | 367.00K | ||||
| Other Long-Term Liabilities | 11.30M | 11.00M | 11.02M | 6.20M | 33.10M | 28.40M |
| Total Liabilities | 55.11M | 57.38M | 64.77M | 40.23M | 56.98M | 53.87M |
| Common Stock | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
| Additional Paid-In Capital | 1.13B | 1.07B | 1.06B | 928.08M | 880.83M | 792.97M |
| Retained Earnings | -1.01B | -967.78M | -902.86M | -770.80M | -682.32M | -595.41M |
| Comprehensive Income & Other | -304.00K | 610.00K | 97.00K | -106.00K | -897.00K | -224.00K |
| Shareholders' Equity | 124.58M | 103.08M | 155.55M | 157.18M | 197.62M | 197.34M |
| Total Liabilities & Equity | 179.69M | 160.46M | 220.33M | 197.41M | 254.60M | 251.21M |
| Total Debt | 1.85M | 2.12M | 2.60M | 3.50M | 2.25M | 2.89M |
| Net Cash (Debt) | 168.77M | 149.25M | 201.30M | 178.38M | 227.56M | 222.76M |
| Net Cash Per Share | 1.31 | 1.22 | 2.60 | 2.56 | 3.49 | 3.93 |
| Filing Date Shares Outstanding | 147.20M | 120.60M | 107.92M | 70.93M | 66.69M | 61.28M |
| Total Common Shares Outstanding | 139.82M | 120.50M | 107.85M | 70.89M | 66.69M | 61.23M |
| Working Capital | 69.52M | 67.67M | 94.36M | 97.90M | 209.61M | 182.10M |
| Book Value Per Share | 0.89 | 0.86 | 1.44 | 2.22 | 2.96 | 3.22 |
| Tangible Book Value | 124.58M | 103.08M | 155.55M | 157.18M | 190.65M | 190.29M |
| Tangible Book Value Per Share | 0.89 | 0.86 | 1.44 | 2.22 | 2.86 | 3.11 |
| Machinery | 4.96M | 4.01M | 3.60M | |||
| Leasehold Improvements | 817.00K | 1.12M | 1.12M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -75.74M | -64.92M | -132.06M | -88.48M | -86.91M | -90.86M |
| Depreciation & Amortization | 421.00K | 454.00K | 807.00K | 863.00K | 797.00K | 923.00K |
| Asset Writedown & Restructuring Costs | 86.91M | 6.63M | ||||
| Stock-Based Compensation | 11.66M | 12.38M | 10.86M | 20.54M | 15.04M | 14.06M |
| Other Operating Activities | 800.00K | 2.30M | 2.50M | -27.27M | 4.70M | 25.09M |
| Change in Accounts Receivable | -1.49M | 6.14M | -4.88M | 186.00K | 139.00K | 149.00K |
| Change in Accounts Payable | 6.70M | 8.45M | -4.19M | -1.47M | 368.00K | 3.65M |
| Change in Unearned Revenue | -3.85M | -3.82M | 23.93M | |||
| Change in Other Net Operating Assets | -552.00K | -8.10M | -3.94M | 10.68M | -1.70M | -5.15M |
| Operating Cash Flow | -62.06M | -47.11M | -20.07M | -78.33M | -67.57M | -52.13M |
| Capital Expenditures | -118.00K | -111.00K | -121.00K | -1.31M | -605.00K | -308.00K |
| Sale (Purchase) of Intangibles | -833.00K | -35.81M | ||||
| Investment in Securities | 3.65M | 49.31M | -33.84M | 47.53M | 13.23M | -167.32M |
| Investing Cash Flow | 3.53M | 48.37M | -69.77M | 46.22M | 12.63M | -167.63M |
| Long-Term Debt Repaid | -11.48M | |||||
| Net Debt Issued (Repaid) | -11.48M | |||||
| Issuance of Common Stock | 58.15M | 80.03M | 27.63M | 72.90M | 239.66M | |
| Repurchase of Common Stock | -435.00K | -446.00K | -409.00K | -102.00K | -34.00K | -3.12M |
| Other Financing Activities | -5.42M | -5.42M | -5.09M | -826.00K | ||
| Financing Cash Flow | 52.29M | -5.86M | 74.54M | 26.71M | 72.87M | 225.05M |
| Net Cash Flow | -6.24M | -4.61M | -15.31M | -5.40M | 17.93M | 5.29M |
| Free Cash Flow | -62.18M | -47.22M | -20.20M | -79.63M | -68.17M | -52.44M |
| Free Cash Flow Margin | -756.50% | -603.42% | -107.89% | -254.84% | -229.13% | -775.65% |
| Free Cash Flow Per Share | -0.48 | -0.39 | -0.26 | -1.14 | -1.04 | -0.92 |
| Levered Free Cash Flow | -41.97M | -30.63M | -59.12M | -37.97M | -39.31M | -28.51M |
| Unlevered Free Cash Flow | -41.97M | -30.63M | -59.12M | -37.97M | -39.31M | -28.51M |
| Change in Working Capital | 802.00K | 2.67M | 10.92M | 9.39M | -1.20M | -1.34M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 588.94M | 326.12M | 265.41M | 74.38M | 1.05B | 890.25M |
| Enterprise Value | 420.17M | 161.15M | 94.68M | -110.47M | 804.58M | 649.68M |
| Last Close Price | 3.80 | 3.01 | 2.48 | 1.05 | 15.75 | 14.54 |
| PS Ratio | 71.66 | 41.67 | 14.18 | 2.38 | 35.30 | 131.67 |
| PB Ratio | 4.26 | 3.16 | 1.71 | 0.47 | 5.32 | 4.51 |
| P/TBV Ratio | 4.73 | 3.16 | 1.71 | 0.47 | 5.51 | 4.68 |
| EV/Sales Ratio | 51.12 | 20.59 | 5.06 | 27.04 | 96.09 | |
| Debt / Equity Ratio | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 |
| Net Debt / Equity Ratio | -1.35 | -1.45 | -1.29 | -1.14 | -1.15 | -1.13 |
| Net Debt / EBITDA Ratio | 1.97 | 2.02 | 3.85 | 1.56 | 3.42 | |
| Net Debt / FCF Ratio | 2.71 | 3.16 | 9.97 | 2.24 | 3.34 | 4.25 |
| Asset Turnover | 0.04 | 0.04 | 0.09 | 0.14 | 0.12 | 0.04 |
| Quick Ratio | 3.46 | 3.36 | 3.99 | 3.86 | 9.94 | 8.38 |
| Current Ratio | 3.46 | 3.36 | 3.99 | 4.16 | 10.55 | 8.94 |
| Return on Equity (ROE) | -59.10% | -50.20% | -84.46% | -49.88% | -44.01% | -77.33% |
| Return on Assets (ROA) | -28.98% | -24.32% | -15.72% | -31.67% | -21.04% | -25.38% |
| Return on Capital Employed (ROCE) | -56.50% | -56.20% | -27.80% | -68.80% | -36.60% | -28.60% |
| Earnings Yield | -15.42% | -19.91% | -49.76% | -118.96% | -8.28% | -10.21% |
| FCF Yield | -10.56% | -14.48% | -7.61% | -107.07% | -6.49% | -5.89% |
| Buyback Yield / Dilution | -25.53% | -58.56% | -10.73% | -7.05% | -14.95% | -33.36% |